VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_16-vv-00803
Package ID: USCOURTS-cofc-1_16-vv-00803
Petitioner: Frederic C. Thompson
Filed: 2018-01-09
Decided: 2018-03-01
Vaccine: influenza
Vaccination date: 2014-09-23
Condition: Guillain-Barré syndrome (GBS)/Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Outcome: compensated
Award amount USD: 247500

AI-assisted case summary:
Frederic Thompson filed a petition on January 9, 2018, alleging that he suffered Guillain-Barré syndrome (GBS)/Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) as a result of his influenza vaccine received on September 23, 2014. He further alleged that he experienced residual effects from this condition for more than six months. The respondent, the Secretary of Health and Human Services, denied that the flu vaccine caused Mr. Thompson's GBS/CIDP or any other injury. Despite maintaining their respective positions, both parties agreed to settle the case through a stipulation filed on January 9, 2018. The stipulation proposed an award of compensation to Mr. Thompson. Special Master Corcoran reviewed the file and found the stipulation to be reasonable, adopting it as the decision. The stipulation awarded Mr. Thompson a lump sum of $247,500.00, representing compensation for all damages available under the National Vaccine Injury Compensation Program. Judgment was to be entered accordingly.

Theory of causation field:
unclear

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_16-vv-00803-0
Date issued/filed: 2018-03-01
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 1/09/2018) Regarding 26 DECISION Stipulation (Signed by Special Master Brian H. Corcoran). (cr) Service on parties made.
--------------------------------------------------------------------------------
Case 1:16-vv-00803-UNJ Document 34 Filed 03/01/18 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 16-803V
(not to be published)
* * * * * * * * * * * * * * * * * * * * * * * * *
FREDERIC C. THOMPSON, *
* Special Master Corcoran
*
Petitioner, * Filed: January 9, 2018
*
v. *
* Decision by Stipulation; Damages;
SECRETARY OF HEALTH * Influenza (“Flu”) Vaccine; Guillain-
AND HUMAN SERVICES, * Barré Syndrome (“GBS”), Chronic
* Inflammatory Demyelinating
Respondent. * Polyneuropathy (“CIDP”).
*
* * * * * * * * * * * * * * * * * * * * * * * * *
Randall Elbert Smith, Smith, Elliot, Smith and Garmey, Saco, ME, for Petitioner.
Camille Michelle Collett, U.S. Dep’t of Justice, Washington, DC, for Respondent.
DECISION AWARDING DAMAGES1
On July 6, 2016, Frederic Thompson filed a petition seeking compensation under the
National Vaccine Injury Compensation Program (“Vaccine Program”).2 Petitioner alleges that he
suffered from Guillain-Barré syndrome (“GBS”)/Chronic Inflammatory Demyelinating
Polyneuropathy (“CIDP”), as a result of his September 23, 2014, influenza (“flu”) vaccine.
Petitioner further alleges that he has experienced the residual effects of this condition for more
than six months.
1 Although this Decision has been formally designated “not to be published,” it will nevertheless be posted on the
Court of Federal Claims’s website in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 (2012). This
means the ruling will be available to anyone with access to the internet. As provided by 42 U.S.C. § 300aa-
12(d)(4)(B), however, the parties may object to the Decision’s inclusion of certain kinds of confidential information.
Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any
information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged
or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly
unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision in its present form will be
available. Id.
2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660,
100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) (“Vaccine Act” or “the Act”).

Case 1:16-vv-00803-UNJ Document 34 Filed 03/01/18 Page 2 of 7
Respondent denies that the flu vaccine caused Petitioner’s GBS/CIDP or any other injury.
Nonetheless both parties, while maintaining their above-stated positions, agreed in a stipulation
(filed on January 9, 2018) that the issues before them could be settled, and that a decision should
be entered awarding Petitioner compensation.
I have reviewed the file, and based upon that review, I conclude that the parties’ stipulation
(as attached hereto) is reasonable. I therefore adopt it as my decision in awarding damages on the
terms set forth therein.
The stipulation awards:
 A lump sum of $247,500.00, in the form of a check payable to Petitioner.
Stipulation ¶ 8. This amount represents compensation for all damages that would be available
under Section 15(a) of the Act.
I approve a Vaccine Program award in the requested amount set forth above to be made to
Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of
the Court is directed to enter judgment herewith.3
IT IS SO ORDERED.
/s/ Brian H. Corcoran
Brian H. Corcoran
Special Master
3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by each filing (either jointly or separately)
a notice renouncing their right to seek review.
2

Case 1:16-vv-00803-UNJ Document 34 Filed 03/01/18 Page 3 of 7

Case 1:16-vv-00803-UNJ Document 34 Filed 03/01/18 Page 4 of 7

Case 1:16-vv-00803-UNJ Document 34 Filed 03/01/18 Page 5 of 7

Case 1:16-vv-00803-UNJ Document 34 Filed 03/01/18 Page 6 of 7

Case 1:16-vv-00803-UNJ Document 34 Filed 03/01/18 Page 7 of 7